Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Tokai J Exp Clin Med ; 48(1): 5-9, 2023 Apr 20.
Article in English | MEDLINE | ID: mdl-36999387

ABSTRACT

A 69-year-old Japanese woman visited Tokai University Oiso hospital with cutaneous ulcers on her left upper arm that appeared in January 2013, and on her right nose that appeared in December of 2013. Neither the two biopsies and tissue culture from the arm lesion nor the biopsy and tissue culture from the nose lesion detected any organism. In December of 2013, she was diagnosed as cutaneous sarcoidosis at Oiso hospital and treated with oral prednisolone for six months, however, did not show improvement. In June of 2014, third skin biopsy and culture from her left upper arm was done at our hospital, and also could not detect any organism. After six months of continuing treatment with oral steroids and steroid injections, the cutaneous ulcers became enlarged, with purulent exudate, requiring a fourth skin biopsy and culture from left upper arm, which finally detected Sporotrichosis. After one-month administration of itraconazole, in January of 2015, cutaneous ulcers of both the arm and nose shrunk. Sporotrichosis mimics sarcoidosis as well as other skin conditions clinically and histologically, therefore recognizing the importance of carrying out multiple skin biopsies and cultures are imperative to prevent misdiagnosis and improper treatments and possible dissemination.


Subject(s)
Sarcoidosis , Sporotrichosis , Humans , Female , Aged , Sporotrichosis/diagnosis , Sporotrichosis/drug therapy , Sporotrichosis/pathology , Antifungal Agents/therapeutic use , Ulcer/drug therapy , Sarcoidosis/diagnosis , Sarcoidosis/drug therapy , Biopsy
2.
Tokai J Exp Clin Med ; 48(1): 10-12, 2023 Apr 20.
Article in English | MEDLINE | ID: mdl-36999388

ABSTRACT

The coronavirus disease 2019 (COVID-19), which is an infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), spread worldwide including Japan. This COVID-19 pandemic has changed the way of life around the world. To prevent the spread of infection, several COVID-19 vaccines were rapidly developed and their vaccination is recommended. While safety and effectiveness of these vaccines have been shown, various adverse reactions occur with a certain frequency. Pilomatricoma is a benign subcutaneous tumor. Cause of pilomatricoma is unclear, however, an external insult could be a cause of part of pilomatricoma. Herein, we report a rare case of pilomatricoma after COVID-19 vaccination. Pilomatricoma should be included in the differential diagnoses of nodular lesions arising after vaccination sites, including the COVID-19 vaccine.


Subject(s)
COVID-19 , Hair Diseases , Pilomatrixoma , Skin Neoplasms , Humans , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Pilomatrixoma/etiology , SARS-CoV-2 , Pandemics , Vaccination/adverse effects , Skin Neoplasms/etiology
3.
Tokai J Exp Clin Med ; 46(1): 26-28, 2021 Apr 20.
Article in English | MEDLINE | ID: mdl-33835472

ABSTRACT

Ticks have a cosmopolitan distribution and, as such, are also found in Japan. Ticks are typically ectoparasites of wild animals, however, humans can also be bitten when visiting environments inhabited by ticks. Herein, we describe two cases with atypical tick bites. Case 1 was an elderly Japanese male patient who presented with a fully engorged tick measuring 20 × 17 × 8 mm; it is rare for ticks to attain a length of 20 mm. Case 2 was an elderly Japanese female with severe dementia who presented with multiple tick bites, which is rare, after going missing for 6 days before being found in a densely wooded area. Ticks are responsible for the transmission of many infectious agents, such as bacteria, viruses and parasites. The National Institute of Infectious Diseases and the Ministry of Health, Labour and Welfare regularly inform citizens of the risks posed by tick bites. However, the tick bites could not be prevented in our patients. Further edification about tick bites, tick-borne diseases, and their prevention are considered necessary in Japan.


Subject(s)
Amblyomma/anatomy & histology , Amblyomma/pathogenicity , Skin/pathology , Skin/parasitology , Tick Bites/diagnosis , Tick Bites/pathology , Aged, 80 and over , Animals , Dermatologic Surgical Procedures/methods , Female , Humans , Japan , Male , Tick Bites/parasitology , Tick Bites/surgery
4.
Tokai J Exp Clin Med ; 45(4): 230-235, 2020 Dec 20.
Article in English | MEDLINE | ID: mdl-33300595

ABSTRACT

OBJECTIVE: To review patients who were treated at Tokai University Hospital with biologic agents for psoriasis vulgaris and psoriatic arthritis and analyze the biological retention rate, reasons for switching biologics, and investigate possible clinical prognostic factor which may affect whether a patient preferred one biologic to another. METHODS: Clinical courses of 63 patients who received biologic agents between Sep of 2010 to June of 2019 were investigated. Biological retention rate of each biologic agents, reasons of switching to another biologic agent, and prognostic factors, if any, between switched and non-switched patients were examined. RESULTS: The biological retention rate of ustekinumab (UST) was significantly longer than that of infliximab (IFX) or adalimumab (ADA). The major reason of switching was due to secondary loss of efficacy. Patients being treated with UST were more likely to switch to another biologic when they exhibited nail lesions. CONCLUSION: These results suggested that biological retention rate of UST was superior than that of IFX or ADA. Furthermore, with patients administered UST, nail symptom suggested possible clinical prognostic factor for switching to other biologic agents.


Subject(s)
Adalimumab/therapeutic use , Biological Factors/therapeutic use , Clinical Reasoning , Drug Substitution , Infliximab/therapeutic use , Psoriasis/drug therapy , Ustekinumab/therapeutic use , Adalimumab/adverse effects , Adalimumab/economics , Adult , Arthritis, Psoriatic/drug therapy , Biological Factors/adverse effects , Biological Factors/economics , Female , Humans , Infliximab/adverse effects , Infliximab/economics , Male , Middle Aged , Nail Diseases/etiology , Prognosis , Pruritus/etiology , Retrospective Studies , Treatment Outcome , Ustekinumab/adverse effects , Ustekinumab/economics
5.
Tokai J Exp Clin Med ; 45(3): 136-138, 2020 Sep 20.
Article in English | MEDLINE | ID: mdl-32901902

ABSTRACT

In recent years, BCG vaccination is routinely performed worldwide. The Ministry of Health, Labor and Welfare of Japan reported that the vaccination rate was as high as 92.9% in 2011. Majority of the reported local adverse reactions to BCG vaccination included lymph node swelling, keloid formation, and abscesses. Subcutaneous tuberculous granuloma is a rare local adverse reaction to BCG vaccination. Herein, we report two cases of developing subcutaneous tuberculous granuloma associated with BCG vaccination. Both of them were treated with isoniazid. There is no standard management for BCG-induced subcutaneous tuberculous granuloma, however, treatment with anti-tuberculosis drugs should be considered for cases of BCGinduced subcutaneous tuberculous granuloma with abscesses or ulcerations.


Subject(s)
BCG Vaccine/adverse effects , Granuloma/etiology , Skin Diseases/etiology , Tuberculosis, Cutaneous/etiology , Antitubercular Agents/therapeutic use , Female , Granuloma/drug therapy , Humans , Infant , Isoniazid/therapeutic use , Male , Treatment Outcome , Tuberculosis, Cutaneous/drug therapy
6.
J Dermatol ; 44(4): 465-467, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27864829

ABSTRACT

A 5-year-old girl noticed a rapidly growing reddish nodule on her right forearm. Although oral antibiotics had been administrated for 2 weeks, the tumor enlarged. Skin biopsy revealed excessive infiltration of atypical neoplastic cells expressing CD4, CD30 and anaplastic lymphoma kinase (ALK). These histological and immunohistochemical findings were consistent with anaplastic large cell lymphoma (ALCL). Computed tomography showed multiple lymphadenopathy, but lymph node biopsy and bone marrow examination did not show any evidence of systemic dissemination. However, due to the positive results for ALK and multiple lymphadenopathy, we diagnosed ALK-positive ALCL forming a solitary skin tumor on the forearm. The patient received chemotherapy and presented marked improvement. This paper discusses the difficulty of diagnosing pediatric ALK-positive ALCL limited to the skin and reviews the medical published work.


Subject(s)
Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lymphoma, Large-Cell, Anaplastic/diagnosis , Receptor Protein-Tyrosine Kinases/metabolism , Skin Neoplasms/diagnosis , Anaplastic Lymphoma Kinase , Biopsy , Cell Nucleus , Child, Preschool , Cytoplasm , Female , Forearm , Humans , Immunohistochemistry , Lymphoma, Large-Cell, Anaplastic/metabolism , Lymphoma, Large-Cell, Anaplastic/pathology , Lymphoma, Large-Cell, Anaplastic/therapy , Skin/pathology , Skin Neoplasms/drug therapy , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
8.
J Dermatol ; 41(6): 521-4, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24815562

ABSTRACT

Granulocyte monocyte apheresis (GMA) is an extracorporeal apheresis instrument that removes activated neutrophils and monocytes. Generalized pustular psoriasis (GPP) is characterized by neutrophil infiltration into the epidermis that causes Kogoj's spongiotic pustule. Thus, GMA is one of the useful therapies for GPP, and it was approved for the treatment in 2012 in Japan. Herein, we report a case of GPP with end-stage renal disease (ESRD) successfully treated with GMA in combination with hemodialysis (HD). A 54-year-old Japanese female visited our outpatient clinic because of erythema with pustules on her trunk and extremities over the past 4 months. Histopathological examination showed an intraepidermal pustule filled with numerous neutrophils and spongiosis. These findings led to the diagnosis of GPP. She had ESRD and had been treated with HD twice a week for approximately 4 years. During maintenance HD twice a week, weekly GMA was started at Tokai University Hospital. The skin symptoms disappeared after five administrations of GMA. We suggest that GMA is an effective therapy for GPP patients with ESRD who are treated with HD.


Subject(s)
Leukapheresis , Psoriasis/therapy , Female , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Middle Aged , Psoriasis/complications , Renal Dialysis
9.
J Dermatol Sci ; 74(3): 204-13, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24702853

ABSTRACT

BACKGROUND: Impaired wound healing in skin ulcer is one of the major medical issues in the aged society. Wound healing is a complex process orchestrated by a number of humoral factors and cellular components. TGF-ß is known to stimulate collagen production in dermal fibroblasts while inhibiting proliferation of epidermal keratinocyte. A screening of small compounds that suppress type I collagen production in fibroblasts has identified HSc025 that antagonizes the TGF-ß/Smad signal. OBJECTIVE: We examined the effects of HSc025 on dermal wound healing and elucidated the underlying mechanisms. METHODS: Effects of HSc025 on the wound closure process were evaluated in a murine full-thickness excisional wound healing model. Cell proliferation and migration were estimated using primary cultures of human keratinocytes and fibroblasts. Comprehensive analyses of gene expression profiles were performed using untreated and HSc025-treated fibroblasts. RESULTS: Oral HSc025 administration suppressed macrophage infiltration and accelerated wound closure as early as at day 2 after the dermal excision. Treatment of cultured keratinocytes with HSc025 counteracted the inhibitory effects of TGF-ß on cell proliferation and migration. On the other hand, HSc025 stimulated migration, but not proliferation, of dermal fibroblasts independently of TGF-ß. Experiments using an artificial dermis graft revealed that HSc025 stimulated migration of collagen-producing cells into the graft tissue. A cDNA microarray analysis of untreated and HSc025-treated fibroblasts identified pirin as a critical mediator accelerating fibroblast migration. CONCLUSION: HSc025 accelerates wound healing by modifying infiltration, proliferation and migration of distinct cellular components, which provides a novel insight into the therapy for intractable skin ulcer.


Subject(s)
Alkadienes/therapeutic use , Skin Ulcer/drug therapy , Wound Healing/drug effects , Alkadienes/pharmacology , Animals , Carrier Proteins/metabolism , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Collagen Type I/genetics , Collagen Type I/metabolism , Dioxygenases , Drug Evaluation, Preclinical , Female , Fibroblasts/drug effects , Granulation Tissue/cytology , Humans , Keratinocytes/drug effects , Mice , Nuclear Proteins/metabolism , Transforming Growth Factor beta
10.
Tokai J Exp Clin Med ; 38(2): 52-4, 2013 Jul 20.
Article in English | MEDLINE | ID: mdl-23868735

ABSTRACT

Disseminated herpes zoster is not rare in immunocompromised patient. It is defined as at least 20 lesions in multiple dermatomes that occur within a week of the onset of local eruption. Herein, we report that a case of disseminated vesicles of herpes zoster (HZ) that developed one day before the onset of local eruption in an immunocompromised patient. A 44 year-old Japanese male, who had been in the hospital with acute myelocytic leukemia, developed disseminated hemorrhagic vesicles of 5 to 10 mm in diameter. The next day, grouped vesicles, including hemorrhagic vesicles erupted on the right side of the second to third cervical (C2-C3) dermatomes. At this point, the diagnosis was made as disseminated herpes zoster. The activation of varicella-zoster virus (VZV) is believed to be due to waning of VZV-specific memory T cell responses. In our case, the memory immunity to VZV which had been increased by last episode of HZ might affect on the appearance of skin eruptions.


Subject(s)
Dermatitis/virology , Herpes Zoster/immunology , Herpes Zoster/virology , Herpesvirus 3, Human/physiology , Hospitalization , Immunocompromised Host/immunology , Immunologic Memory/immunology , T-Lymphocytes/immunology , Virus Activation/immunology , Adult , Dermatitis/immunology , Dermatitis/pathology , Herpes Zoster/pathology , Humans , Leukemia, Myeloid, Acute/immunology , Male , Skin/immunology , Skin/pathology , Skin/virology , Time Factors
11.
J Dermatol ; 40(9): 700-5, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23802993

ABSTRACT

To evaluate the diagnostic usefulness of Doppler sonography for amelanotic melanoma (AM), the correspondence between the findings of dermoscopy and Doppler sonography was investigated in AM in comparison with other hypopigmented tumors. Seven cases with AM and 11 cases with squamous cell carcinoma (SCC), 10 cases with non- or hypopigmented basal cell carcinoma (NP-BCC) and six cases with eccrine poroma (EP) as hypopigmented tumors were investigated. EP is readily recognized by differences from AM and SCC based on a single vertical and non-torvtuous vessels. NP-BCC is distinguished from AM based on tortuosity running in a vertical direction. Though findings of tortuosity in vessels and heterogeneity of vessel size are recognized both in AM and SCC: (i) abundant blood flow was recognized more clearly in AM; (ii) total blood flow was more than 40% in most cases of AM (average, 60.9%); and (iii) more vessels which flow into a tumor are found in AM (85.7%). There is no relationship between dermoscopic findings of vessel types and Doppler sonography findings of vessels. In this study, the diagnostic usefulness of the above-mentioned specific findings in examination may suggest using Doppler sonography for AM as one non-invasive method.


Subject(s)
Melanoma, Amelanotic/diagnostic imaging , Skin Neoplasms/diagnostic imaging , Carcinoma, Basal Cell/diagnostic imaging , Carcinoma, Squamous Cell/diagnostic imaging , Dermoscopy , Humans , Poroma/diagnostic imaging , Retrospective Studies , Ultrasonography, Doppler
12.
J Dermatol ; 40(4): 238-43, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23330814

ABSTRACT

Various therapies have been tried for psoriasis. In Japan, biologics began to be used for psoriasis treatment in January 2010. Their clinical efficacy is well known, but biologics cannot be used in all psoriasis patients for reasons such as side-effects and cost. It is necessary to evaluate the effect of long-term psoriasis treatment, but there have been no reports evaluating long-term treatment. Therefore, the outcomes of patients who had been treated at the Tokai University Hospital for more than 5 years, before biological agents were released, were examined. Three categories, classified by initial severity, changes in severity by method of treatment and background characteristics, were investigated. In conclusion, cases of long-term treatment with a combination of topical corticosteroid and topical vitamin D3 analog or oral cyclosporin were found to be effective therapies. Patients with a history of diabetes mellitus or cardiovascular disease of psoriasis were likely to be treatment resistant.


Subject(s)
Cholecalciferol/therapeutic use , Cyclosporine/therapeutic use , Dermatologic Agents/therapeutic use , Etretinate/therapeutic use , Glucocorticoids/therapeutic use , Phototherapy/methods , Psoriasis/drug therapy , Administration, Oral , Administration, Topical , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cholecalciferol/adverse effects , Cholecalciferol/analogs & derivatives , Cyclosporine/adverse effects , Dermatologic Agents/adverse effects , Drug Combinations , Etretinate/adverse effects , Female , Follow-Up Studies , Glucocorticoids/adverse effects , Humans , Japan , Male , Middle Aged , Severity of Illness Index , Time Factors , Treatment Outcome , Young Adult
13.
Tokai J Exp Clin Med ; 37(3): 75-6, 2012 Sep 20.
Article in English | MEDLINE | ID: mdl-23032248

ABSTRACT

A 72-year-old woman visited our clinic with fever of unknown origin above 38°C and arthralgia from 7 months before. Her symptoms recurred as oral steroid was reduced. Random skin biopsy was carried out from five points. One of the five specimens taken from abdomen revealed large atypical lymphoid cells in the vascular space of subcutaneous fat. Immunohistochemical analysis showed that these cells were positive for CD20, CD79a, bcl-2, bcl-6 and MUM-1. From these findings, a diagnosis of intravascular large B cell lymphoma was made.


Subject(s)
Lymphoma, B-Cell/diagnosis , Vascular Neoplasms/diagnosis , Aged , Antigens, CD20/metabolism , Biopsy/methods , CD79 Antigens/metabolism , DNA-Binding Proteins/metabolism , Female , Humans , Immunohistochemistry , Interferon Regulatory Factors/metabolism , Lymphoma, B-Cell/metabolism , Neoplasm Invasiveness/diagnosis , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-bcl-6 , Skin/blood supply , Skin/pathology , Vascular Neoplasms/metabolism
14.
Tokai J Exp Clin Med ; 37(3): 84-8, 2012 Sep 20.
Article in English | MEDLINE | ID: mdl-23032250

ABSTRACT

OBJECTIVE: The aim of this study was to assess the quality of life (QOL) of patients with psoriasis in Japan using Dermatology Life Quality Index (DLQI). Furthermore, we had evaluated the correlation between DLQI and clinical severity of psoriasis. METHODS: The Japanese version of DLQI was used to assess the QOL of patients. Psoriasis area and severity index (PASI) and Itch visual analogue scale (VAS) were used to assess clinical severity of psoriasis. RESULTS: The subjects were 102 Japanese patients with mild to severe psoriasis (77 males, 25 females, mean age 55.2 ± 14.2). There were no statistically significant differences in age, PASI, and itch VAS between male and female. The mean DLQI scores in total were 3.6 ± 3.2 in male and 7.2 ± 1.2 in female. The mean total DLQI scores in female were higher than that in male (p = 0.0016). Significant correlation was observed between DLQI scores and PASI score (p < 0.001) or itch VAS score (p < 0.001). CONCLUSIONS: The mean total DLQI scores in female were significantly higher than that in male. Also, we confirmed the correlation between DLQI and clinical severity of psoriasis. These findings suggest that QOL assessment plays a greater role in females than in the males, when assessing the severity of psoriasis.


Subject(s)
Psoriasis/psychology , Adult , Aged , Female , Humans , Japan , Male , Middle Aged , Psoriasis/pathology , Psoriasis/physiopathology , Quality of Life , Severity of Illness Index , Sex Characteristics , Surveys and Questionnaires
16.
Tokai J Exp Clin Med ; 36(2): 53-7, 2011 Jul 20.
Article in English | MEDLINE | ID: mdl-21769774

ABSTRACT

A 81-year-old man with a patch of scaly erythema on his scrotum visited Hiratsuka Kyosai Hospital in June 2006. Reddish, scaly plaques, which were untreated, were present on his back and lower legs since 1999. Pathological examination of the lesions on the scrotum revealed Bowen's disease; therefore he was referred to our clinic for further treatment. During his visit Tokai University Hospital, irregularly bordered scaly erythematous patches were observed on his back, left arm, right knee, and right foot, sizing from 2 to 4 cm in diameter. He was treated with phenol and liquid nitrogen cryotherapy; however, he dropped out of clinic after receiving treatment for a year. At this point, most lesions were cured and only scars remained. In June 2009, he revisited Tokai University Hospital, and this time, multiple scaly erythematous patches were noted on his back and both the arms and legs. The results of the biopsies of 4 lesions obtained from the back, right arm, right knee, and the right foot led to the diagnosis of multiple Bowens' disease. During the inquiry, we learned that since birth, he has resided in Hiratsuka City and had often used water from wells. We researched the possibilities of water and soil contaminations in the Hiratsuka area.


Subject(s)
Arsenic/toxicity , Bowen's Disease/etiology , Environmental Exposure/adverse effects , Skin Neoplasms/etiology , Water Pollutants, Chemical/toxicity , Aged, 80 and over , Arsenic Poisoning/complications , Arsenic Poisoning/diagnosis , Bowen's Disease/pathology , Bowen's Disease/therapy , Cryotherapy , Humans , Japan , Male , Skin Neoplasms/pathology , Skin Neoplasms/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...